Algo version: 0.98b
Shanghai Pharmaceuticals is listed at the SHH Exchange
Shanghai Pharmaceuticals [601607.SS]
SHH Sector: Healthcare Industry:Medical Distribution

Is Shanghai Pharmaceuticals stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Shanghai Pharmaceuticals pays dividends. Last time was Monday 22nd of July 2024 where the investors holding the stock on Monday 22nd of July 2024 were paid CNY0.41 per share. Over the last 28 times between 1995 and 2024, Shanghai Pharmaceuticals has paid CNY6.4485 with an average of CNY0.23 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Shanghai Pharmaceuticals 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was CNY19.46, you would have made a loss of CNY-0.210 per share or -1.08%

Yes, the average daily trading liquidity for Shanghai Pharmaceuticals is CNY10.80 million. You should therefore be able to get in and out of your positions relatively fast.

Shanghai Pharmaceuticals has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a low cash flow to debt ratio of 0.05, the company's ability to pay off the debt is limited. The company has a very low net profit margin of 1.44%, which is challenging.

We have calculated the inflation risk for Shanghai Pharmaceuticals to be medium [0.65 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.